1. Home
  2. KMPR vs SRPT Comparison

KMPR vs SRPT Comparison

Compare KMPR & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kemper Corporation

KMPR

Kemper Corporation

N/A

Current Price

$34.15

Market Cap

1.7B

Sector

Finance

ML Signal

N/A

Logo Sarepta Therapeutics Inc. (DE)

SRPT

Sarepta Therapeutics Inc. (DE)

N/A

Current Price

$16.12

Market Cap

2.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
KMPR
SRPT
Founded
1990
1980
Country
United States
United States
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
2.0B
IPO Year
1995
2000

Fundamental Metrics

Financial Performance
Metric
KMPR
SRPT
Price
$34.15
$16.12
Analyst Decision
Hold
Hold
Analyst Count
6
24
Target Price
★ $37.33
$21.77
AVG Volume (30 Days)
809.0K
★ 2.2M
Earning Date
11-09-2026
11-05-2026
Dividend Yield
★ 3.73%
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ 2.78
Revenue
★ $4,789,700,000.00
$2,198,237,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
$5.78
Revenue Growth
★ 3.26
N/A
52 Week Low
$22.69
$14.68
52 Week High
$41.74
$24.68

Technical Indicators

Market Signals
Indicator
KMPR
SRPT
Relative Strength Index (RSI) 61.76 37.20
Support Level $28.62 $15.19
Resistance Level $34.64 $18.26
Average True Range (ATR) 1.52 0.92
MACD 0.02 -0.25
Stochastic Oscillator 68.55 8.92

Price Performance

Historical Comparison
KMPR
SRPT

About KMPR Kemper Corporation

Kemper Corp is an insurance holding company that offers complementary insurance products through its subsidiaries, including personal and commercial automobile insurance to consumers in targeted markets and industries. Kemper also offers life and other insurance solutions based on the needs of its clients. The company offers its insurance products through a vast network of agents and brokers, mainly under the Kemper Auto and Kemper Life brands. It has two operating segments: Specialty Property & Casualty Insurance and Life Insurance. The majority of the company's revenue is generated from the Specialty Property & Casualty Insurance segment, whose principal products are specialty personal automobile and commercial automobile insurance. Geographically, it operates only in the United States.

About SRPT Sarepta Therapeutics Inc. (DE)

Sarepta Therapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, gene therapies, and other genetic medicines for rare diseases, particularly neuromuscular disorders. The company has developed approved treatments for Duchenne muscular dystrophy, including EXONDYS 51, VYONDYS 53, AMONDYS 45, and ELEVIDYS, and is advancing additional therapeutic candidates for neuromuscular and other rare diseases. The company operates in one segment: discovering, developing, manufacturing, and delivering therapies to patients with rare diseases.

Share on Social Networks: